Focus: Coronavirus Channel Featured Story 2

Filters close
12-Dec-2023 3:05 PM EST
‘Long flu’ has emerged as a consequence similar to long COVID
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.

7-Feb-2023 9:00 AM EST
Tobacco and e-cigs may put healthy young people at risk of severe COVID illness, new UCLA research suggests
University of California, Los Angeles (UCLA), Health Sciences

Smoking tobacco and vaping electronic cigarettes may increase healthy young people’s risk for developing severe COVID illness.

Newswise: Alcoholic Pancreatitis Patients with Continued Alcohol Intake May Finally Have Therapeutic Options
Released: 21-Oct-2022 2:50 PM EDT
Alcoholic Pancreatitis Patients with Continued Alcohol Intake May Finally Have Therapeutic Options
University of Miami Health System, Miller School of Medicine

Researchers at the Miller School are looking for solutions to the continued effects of alcohol use, its harmful impact, and treatment. Understanding the mechanisms of alcohol abuse has gained importance, especially after the COVID-19 pandemic. Higher alcohol consumption led to an increased burden of pancreatic diseases in society.

Newswise: Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
Released: 18-Oct-2022 8:30 AM EDT
Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
Florida Atlantic University

FAU researchers and collaborators provide the most updated guidance to health care providers and urge how widespread vaccination with these boosters can now avoid the specter of future and more lethal variants becoming a reality.

Released: 19-Sep-2022 4:50 PM EDT
Facemask can detect viral exposure from a 10-minute conversation with an infected person
Cell Press

Scientists have created a face mask that can detect common respiratory viruses, including influenza and the coronavirus, in the air in droplets or aerosols.

Released: 18-May-2022 5:00 PM EDT
COVID Booster Needed for Broad Protection Against Omicron Variants
Ohio State University

A COVID-19 booster shot will provide strong and broad antibody protection against the range of omicron sublineage variants of the SARS-CoV-2 virus in circulation, two new studies using serum from human blood samples suggest.

Newswise: Scientists Use Machine Learning Models to Help Identify Long COVID Patients
Released: 17-May-2022 2:10 PM EDT
Scientists Use Machine Learning Models to Help Identify Long COVID Patients
University of North Carolina School of Medicine

Clinical scientists used machine learning models to explore de-identified electronic health record data in the National COVID Cohort Collaborative (N3C) to help discern characteristics of people with long COVID and factors that may help identify such patients using data from medical records.

Newswise: Chemical Found in Leafy Greens Shown to Slow Growth of COVID-19 and Common Cold Viruses
Released: 23-Mar-2022 12:45 PM EDT
Chemical Found in Leafy Greens Shown to Slow Growth of COVID-19 and Common Cold Viruses
Johns Hopkins Medicine

Researchers at Johns Hopkins Children’s Center report evidence from lab experiments that a chemical derived from a compound found abundantly in broccoli and other cruciferous plants may offer a potentially new and potent weapon against the viruses that cause COVID-19 and the common cold.

Released: 17-Mar-2022 12:20 PM EDT
Memory and concentration problems are common in long COVID and must not be ignored, say scientists
University of Cambridge

Around 70% of long COVID patients in a new study experienced difficulty concentrating and memory problems several months after infection with the virus SARS-CoV-2.

Released: 10-Mar-2022 4:15 PM EST
Antivirals, some antibodies, work well against BA.2 omicron variant of COVID-19 virus
University of Wisconsin–Madison

The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19. The BA.2 variant also remains susceptible to at least some of the monoclonal antibodies used to treat COVID-19, such as Evusheld by AstraZeneca.

Newswise: Did COVID-19 Make Tinnitus, ‘Ringing’ in the Ears, Worse?
Released: 2-Mar-2022 8:30 AM EST
Did COVID-19 Make Tinnitus, ‘Ringing’ in the Ears, Worse?
Florida Atlantic University

Many people impacted by COVID-19 experienced changes in their sense of smell, taste, hearing, balance and in some cases, tinnitus, “ringing” in the ears. Among the various causes of tinnitus is stress. What’s unclear, however, is whether the psychological impacts of the pandemic such as stress actually worsened tinnitus. Results of a new study do not support the idea that the pandemic led to a worsening of tinnitus.

Newswise: Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children
Released: 7-Feb-2022 12:05 PM EST
Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children
Johns Hopkins Medicine

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma — a blood product collected from patients recovered from infections with the coronavirus (SARS-CoV-2) that causes COVID-19— was safe in high risk children infected with or exposed to the virus.

Released: 7-Feb-2022 11:05 AM EST
COVID-19 infections increase risk of heart conditions up to a year later
Washington University in St. Louis

An analysis of federal health data indicates that people who have had COVID-19 are at increased risk of developing cardiovascular complications within the first month to a year after infection, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

Newswise: ‘She Was No Longer My Sister’ – University of Kentucky Neurologists Help Patient Suffering from COVID-Induced Psychosis
Released: 27-Jan-2022 2:35 PM EST
‘She Was No Longer My Sister’ – University of Kentucky Neurologists Help Patient Suffering from COVID-Induced Psychosis
University of Kentucky

Aleina and Kelly Milligan are more than sisters - they are truly best friends. For Kelly, her older sister has been a lifeline during the past two years. As Kelly settled in with her sister in Columbia, Kentucky, Aleina became concerned when she noticed a change in Kelly’s seizure patterns. The sisters then made the trip to Lexington for an appointment with UK HealthCare’s Sally Mathias, M.D., assistant professor of Neurology, who specializes in epilepsy.

Released: 12-Jan-2022 12:40 PM EST
How to Protect Yourself During the Omicron COVID-19 Surge: How to Go Out Safely

Michael Lin, MD, MPH, an infectious disease specialist, explains how risky some activities are now as the highly transmissible omicron variant surges through Chicago and the rest of the country.

Newswise: Do you need a COVID-19 booster shot?
Released: 16-Nov-2021 9:00 AM EST
Do you need a COVID-19 booster shot?
University of Georgia

If you got the COVID-19 shots back in early spring, your antibodies are likely waning. But it’s not something you need to be worried about, according to a new study from the University of Georgia.

5-Nov-2021 4:15 PM EDT
COVID-19: The older you are, the more antibodies you have
Universite de Montreal

Université de Montréal chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus.

Released: 1-Nov-2021 2:00 PM EDT
In Covid-19 Vaccinated People, Those with Prior Infection Likely to Have More Antibodies
Johns Hopkins Medicine

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

Released: 18-Oct-2021 4:05 PM EDT
End-of-life care program at UCLA benefited dying patients and loved ones despite COVID restrictions
University of California, Los Angeles (UCLA), Health Sciences

A program offered by UCLA Health’s intensive care units is providing meaningful and compassionate support for dying patients and their families, despite the challenges brought about by COVID-19.

Released: 14-Oct-2021 8:00 AM EDT
Young ‘Social Butterfly’ Takes on Life-Threatening COVID-19 Complication and Wins
Johns Hopkins Medicine

When 8-year-old Morgan Deitz, known for her “spunky” and “social” personality, came down with COVID-19 in late July 2021, the symptoms were no more than your average cold. “She was a little fatigued, had a runny nose and her throat was a little sore,” her mom, Lauren Deitz, recalls of the symptoms that lasted about two days.

Newswise:Video Embedded vitamin-d-and-lumisterol-emerge-as-cheap-and-easily-accessible-possible-treatments-for-covid-19
Released: 9-Sep-2021 8:00 AM EDT
Vitamin D Emerges as Possible Treatment for COVID-19
American Physiological Society (APS)

Promising new data from a recent study indicates that active forms of vitamin D can inhibit the replication and expansion of COVID-19.

Released: 8-Sep-2021 9:00 AM EDT
Early social distancing results in smaller death tolls, but leads to larger second waves
Binghamton University, State University of New York

Early social distancing results in smaller death tolls, but leads to larger second waves, according to research led by faculty at Binghamton University, State University of New York.

Released: 7-Sep-2021 12:10 PM EDT
Optical Techniques Offer Fast, Efficient COVID-19 Detection
American Institute of Physics (AIP)

Without the prospect of herd immunity on the immediate horizon, speedy detection for COVID-19 remains imperative for helping to curb the pandemic. Point-of-care testing that can provide immediate results is an urgent need. Researchers investigated the opportunities and challenges in developing rapid COVID-19 sensing techniques and discuss the prospects of optical biosensors for point-of-care COVID-19 testing in the journal Applied Physics Reviews.

3-Sep-2021 1:20 PM EDT
These fridge-free COVID-19 vaccines are grown in plants and bacteria
University of California San Diego

Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.

1-Sep-2021 5:00 PM EDT
New study: Nursing home residents, health care workers lose more than 80% of their COVID-19 immunity six months after Pfizer vaccine
Case Western Reserve University

A new, multi-institutional study led by Case Western Reserve University—in partnership with Brown University—found that COVID-19 antibodies produced by the Pfizer vaccine decreased sharply in senior nursing home residents and their caregivers six months after receiving their second shots.

Released: 1-Sep-2021 5:30 PM EDT
With Time and Without Masks, COVID-19 Vaccines Wane in Protection
UC San Diego Health

A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.

Released: 31-Aug-2021 12:50 PM EDT
Mayo Clinic urges cancer patients to seek third dose of mRNA COVID-19 vaccine
Mayo Clinic

Mayo Clinic Cancer Center announced on Tuesday, Aug. 31, that it is following recommendations from the National Comprehensive Cancer Network that encourage cancer patients to receive a third dose of a messenger RNA COVID-19 vaccine. The Moderna and Pfizer COVID-19 vaccines are messenger RNA vaccines.

Released: 25-Aug-2021 10:55 AM EDT
Breast milk of mothers who received COVID-19 vaccine contains antibodies that fight illness
University of Florida

The breast milk of lactating mothers vaccinated against COVID-19 contains a significant supply of antibodies that may help protect nursing infants from the illness, according to new research from the University of Florida.

Released: 23-Aug-2021 10:25 AM EDT
Lancet Respiratory Medicine study: Awake prone positioning can prevent intubation in covid-19 patients

A six country clinical study of more than 1,100 hospitalized COVID-19 patients who required high-flow nasal cannula oxygen therapy suggests that prone positioning (rotating patients with severe breathing issues so they are face down) soon after admission can significantly reduce the need for mechanical ventilation.

Released: 20-Aug-2021 3:35 PM EDT
Antibody protects against broad range of COVID-19 virus variants
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have identified an antibody that is highly protective against a broad range of viral variants.

Released: 17-Aug-2021 12:45 PM EDT
3 Common COVID Vaccination Objections & How to Debunk Them
University of Nevada, Las Vegas (UNLV)

A year ago, the misinformation about coronavirus focused on it being an elaborate hoax, rather than a global health crisis. While more and more people now accept that it is a threat, they don’t necessarily accept that vaccines are our best way to counter it. And sadly, our hospital ICUs are filled with people who have not been vaccinated.

Released: 17-Aug-2021 11:35 AM EDT
Antibodies elicited by COVID-19 vaccination effective against delta variant
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have found that the delta variant of the virus that causes COVID-19 is largely unable to evade antibodies elicited by vaccination. The findings help explain why vaccinated people have been at low risk of getting seriously ill with COVID-19 despite a surge in cases caused by the delta variant.

Released: 16-Aug-2021 2:55 PM EDT
Penn Study Details Robust T-Cell Response to mRNA COVID-19 Vaccines—a More Durable Source of Protection
Perelman School of Medicine at the University of Pennsylvania

Messenger-RNA (mRNA) vaccines against the coronavirus that causes COVID-19 provoke a swift and strong response by the immune system’s T cells—the heavy armor of the immune system—according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania.

Released: 5-Aug-2021 8:45 AM EDT
Persistent COVID-19 Infections in Immunocompromised People May Give Rise to Variants of Concern
Fred Hutchinson Cancer Center

In an article in the New England Journal of Medicine, scientists from Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Medicine, the U.S. Military HIV Research Program and the Institute for Global Health and Infectious Diseases at the University of North Carolina urged increased attention to persistent COVID-19 infections in immunocompromised people.

Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 28-Jul-2021 2:45 PM EDT
Highly Potent, Stable Nanobodies Stop SARS-CoV-2
Max Planck Society (Max-Planck-Gesellschaft)

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

Released: 26-Jul-2021 2:00 PM EDT
Why Do Some People Get Severe COVID-19? The Nose May Know
Boston Children's Hospital

The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx.

Released: 15-Jul-2021 2:30 PM EDT
Common Medication Used to Reduce Cholesterol Levels May Reduce COVID-19 Severity
UC San Diego Health

Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.

Released: 12-Jul-2021 10:30 AM EDT
A Third of Teens, Young Adults Reported Worsening Mental Health During Pandemic
Ohio State University

As typical social and academic interaction screeched to a halt last year, many young people began experiencing declines in mental health, a problem that appeared to be worse for those whose connections to family and friends weren’t as tight, a new study has found.

Released: 6-Jul-2021 3:40 PM EDT
Study Shows Laboratory Developed Protein Spikes Consistent with COVID-19 Virus
University of Southampton

A new international study has found that the key properties of the spikes of SARS-CoV-2 virus which causes COVID-19 are consistent with those of several laboratory-developed protein spikes, designed to mimic the infectious virus.

Released: 29-Jun-2021 12:10 PM EDT
Reported Cases of Myocarditis in Younger Men Following COVID-19 Vaccination are Rare; Vaccination Remains Important
Mayo Clinic

Mayo Clinic researchers are taking a close look at rare cases of inflammation of the heart muscle, or myocarditis, in young men who developed symptoms shortly after receiving the second dose of the Moderna or Pfizer messenger RNA (mRNA) COVID-19 vaccines. Several recent studies suggest that health care professionals should watch for hypersensitivity myocarditis as a rare adverse reaction to being vaccinated for COVID-19. However, researchers stress that this awareness should not diminish overall confidence in vaccination during the current pandemic.

Released: 28-Jun-2021 8:05 AM EDT
Mask-Wearing Reduces COVID-19 Transmission, Study Finds
University of Bristol

Mask-wearing is associated with a significant reduction in COVID-19 transmission and factors other than mandates contributed to the global uptake of mask-wearing in 2020, new research has found.

Released: 24-May-2021 7:05 AM EDT
Good news: Mild COVID-19 induces lasting antibody protection
Washington University in St. Louis

People who have had a mild case of COVID-19 are left with long-term antibody protection against future disease, according to a study from researchers at Washington University School of Medicine in St. Louis.

Released: 20-May-2021 1:55 PM EDT
‘Brain fog’ persists among COVID-19 long-haulers
DePaul University

As people with long-haul COVID-19 continue to recover from their illness, neurocognitive symptoms may persist or even worsen over time, as reported in new findings from researchers at DePaul University.

Released: 13-May-2021 8:00 AM EDT
Dental procedures during pandemic are no riskier than a drink of water
Ohio State University

A new study’s findings dispel the misconception that patients and providers are at high risk of catching COVID-19 at the dentist’s office.

Released: 26-Apr-2021 12:35 PM EDT
Nanobodies inhibit SARS-CoV-2 infection
Walter & Eliza Hall Institute

Australian researchers have identified neutralising nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.

Released: 22-Apr-2021 2:55 PM EDT
Pregnant women with COVID-19 face high mortality rate
University of Washington School of Medicine

In a worldwide study of 2,100 pregnant women, those who contracted COVID-19 during pregnancy were 20 times more likely to die than those who did not contract the virus.

Showing results 1 – 50 of 97